دورية أكاديمية

Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020-December 2021.

التفاصيل البيبلوغرافية
العنوان: Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020-December 2021.
المؤلفون: Chea N; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Eure T; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Alkis Ramirez R; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Zlotorzynska M; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Blazek GT; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Chenega Enterprise Systems and Solutions, LLC, Chesapeake, VA, USA., Nadle J; California Emerging Infections Program, Oakland, CA, USA., Lee J; California Emerging Infections Program, Oakland, CA, USA., Czaja CA; Colorado Department of Public Health and Environment, Denver, CO, USA., Johnston H; Colorado Department of Public Health and Environment, Denver, CO, USA., Barter D; Colorado Department of Public Health and Environment, Denver, CO, USA., Kellogg M; Colorado Department of Public Health and Environment, Denver, CO, USA., Emanuel C; Colorado Department of Public Health and Environment, Denver, CO, USA., Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA., Brackney M; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA., Carswell S; Georgia Emerging Infections Program, Atlanta Veterans Affairs Medical Center, Foundation for Atlanta Veterans Education and Research, Atlanta, GA, USA., Thomas S; Georgia Emerging Infections Program, Atlanta Veterans Affairs Medical Center, Foundation for Atlanta Veterans Education and Research, Atlanta, GA, USA., Fridkin SK; Georgia Emerging Infections Program, Emory University School of Medicine, Atlanta, GA, USA., Wilson LE; Maryland Department of Health, Baltimore, MD, USA., Perlmutter R; Maryland Department of Health, Baltimore, MD, USA., Marceaux-Galli K; Maryland Department of Health, Baltimore, MD, USA., Fell A; Minnesota Department of Health, St. Paul, MN, USA., Lovett S; Minnesota Department of Health, St. Paul, MN, USA., Lim S; Minnesota Department of Health, St. Paul, MN, USA., Lynfield R; Minnesota Department of Health, St. Paul, MN, USA., Shrum Davis S; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, NM, USA., Phipps EC; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, NM, USA.; New Mexico Department of Health, Santa Fe, NM, USA., Sievers M; New Mexico Department of Health, Santa Fe, NM, USA., Dumyati G; New York Emerging Infections Program, University of Rochester Medical Center, Rochester, NY, USA., Myers C; New York Emerging Infections Program, University of Rochester Medical Center, Rochester, NY, USA., Hurley C; New York Emerging Infections Program, University of Rochester Medical Center, Rochester, NY, USA., Licherdell E; New York Emerging Infections Program, University of Rochester Medical Center, Rochester, NY, USA., Pierce R; Public Health Division, Oregon Health Authority, Portland, OR, USA., Ocampo VLS; Public Health Division, Oregon Health Authority, Portland, OR, USA., Hall EW; Oregon Health and Science University and Portland State University School of Public Health, Oregon Health and Science University, Portland, OR, USA., Wilson C; Tennessee Department of Health, Nashville, TN, USA., Adre C; Tennessee Department of Health, Nashville, TN, USA., Kirtz E; Tennessee Department of Health, Nashville, TN, USA., Markus TM; Vanderbilt University Medical Center, Nashville, TN, USA., Billings K; Vanderbilt University Medical Center, Nashville, TN, USA., Plumb ID; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Abedi GR; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., James-Gist J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Magill SS; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Grigg CT; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
المصدر: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2024 May 21, pp. 1-9. Date of Electronic Publication: 2024 May 21.
Publication Model: Ahead of Print
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cambridge University Press Country of Publication: United States NLM ID: 8804099 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-6834 (Electronic) Linking ISSN: 0899823X NLM ISO Abbreviation: Infect Control Hosp Epidemiol Subsets: MEDLINE
أسماء مطبوعة: Publication: Jan. 2015- : Cambridge : Cambridge University Press
Original Publication: [Thorofare, N.J. ] : SLACK Inc., c1988-
مستخلص: Background: Understanding characteristics of healthcare personnel (HCP) with SARS-CoV-2 infection supports the development and prioritization of interventions to protect this important workforce. We report detailed characteristics of HCP who tested positive for SARS-CoV-2 from April 20, 2020 through December 31, 2021.
Methods: CDC collaborated with Emerging Infections Program sites in 10 states to interview HCP with SARS-CoV-2 infection (case-HCP) about their demographics, underlying medical conditions, healthcare roles, exposures, personal protective equipment (PPE) use, and COVID-19 vaccination status. We grouped case-HCP by healthcare role. To describe residential social vulnerability, we merged geocoded HCP residential addresses with CDC/ATSDR Social Vulnerability Index (SVI) values at the census tract level. We defined highest and lowest SVI quartiles as high and low social vulnerability, respectively.
Results: Our analysis included 7,531 case-HCP. Most case-HCP with roles as certified nursing assistant (CNA) (444, 61.3%), medical assistant (252, 65.3%), or home healthcare worker (HHW) (225, 59.5%) reported their race and ethnicity as either non-Hispanic Black or Hispanic. More than one third of HHWs (166, 45.2%), CNAs (283, 41.7%), and medical assistants (138, 37.9%) reported a residential address in the high social vulnerability category. The proportion of case-HCP who reported using recommended PPE at all times when caring for patients with COVID-19 was lowest among HHWs compared with other roles.
Conclusions: To mitigate SARS-CoV-2 infection risk in healthcare settings, infection prevention, and control interventions should be specific to HCP roles and educational backgrounds. Additional interventions are needed to address high social vulnerability among HHWs, CNAs, and medical assistants.
فهرسة مساهمة: Keywords: COVID-19; Healthcare personnel; SARS-CoV-2; social vulnerability
تواريخ الأحداث: Date Created: 20240521 Latest Revision: 20240521
رمز التحديث: 20240521
DOI: 10.1017/ice.2024.71
PMID: 38770586
قاعدة البيانات: MEDLINE
الوصف
تدمد:1559-6834
DOI:10.1017/ice.2024.71